Almotriptan Malate Tablet, Film Coated
Product Images NDC 0378-5246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Almotriptan Malate (NDC 0378-5246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Estimated Probability Of Achieving An Initial Headache Response (mild Or No Pain) In 2 Hours In Adults (Image 01)

Figure 1. Estimated Probability Of Achieving An Initial Headache Response (mild Or No Pain) In 2 Hours In Adults (Image 01)
FDA Label Image

Figure 2. Estimated Probability Of Adult Patients Taking Escape Medication Or A Second Dose Of Study Medication Over The 24 Hours Following The Initial Dose Of Study Treatment (Image 02)

Figure 2. Estimated Probability Of Adult Patients Taking Escape Medication Or A Second Dose Of Study Medication Over The 24 Hours Following The Initial Dose Of Study Treatment (Image 02)
This is a not-available description. The given text only contains a partial word "Hours" and some numbers with unit labels, but the overall context and meaning is not clear. It is likely a part of a larger graph or data table related to the drug Amotiptan and its effect on probability at different time intervals after a particular dosage.*
FDA Label Image

Figure 3. Estimated Probability Of Achieving An Initial Headache Response (mild Or No Pain) In 2 Hours In The Adolescent Study (Image 03)

Figure 3. Estimated Probability Of Achieving An Initial Headache Response (mild Or No Pain) In 2 Hours In The Adolescent Study (Image 03)
This appears to be a graph showing the estimated probability of response to a medication (almotriptan) at different time points post-dose (in hours). The probability of response is shown on the y-axis, while the x-axis shows the different doses of almotriptan (6.25mg and 12.5mg) as well as a placebo (marked with -).*
FDA Label Image

Almotriptan Malate Structural Formula (Image 04)

Almotriptan Malate Structural Formula (Image 04)
FDA Label Image

Almotriptan Tablets, Usp 6.25 mg Carton Label (Image 05)

Almotriptan Tablets, Usp 6.25 mg Carton Label (Image 05)
This is a description of a medication called Almotriptan that comes in tablet form as six unit-dose tablets. Each tablet contains .75g of Imatriptan malate, equivalent to 0.6.25g of Almotriptan. The usual dosage is included with the accompanying prescription information. It should be stored at room temperature and kept out of reach of children. The manufacturer is Mylan Pharmaceuticals and the NDC code is 0378-5245-85.*
FDA Label Image

Almotriptan Tablets, Usp 12.5 mg Carton Label (Image 06)

Almotriptan Tablets, Usp 12.5 mg Carton Label (Image 06)
This is a medication package of tablets with the NDC code 0378-5246-85, with a usual dosage of 7.5g of Motitan malate equivalent to 12.5 mo of amitan. The package contains 12 unit-dose tablets and should be stored at a controlled room temperature between 10°-25°C. The manufacturer is Mylan Pharmocouticss. No other information is available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.